Similar articles for PMID: 31806775

Year	Number of Results
2005	2
2006	3
2007	1
2008	1
2009	6
2010	9
2011	12
2012	7
2013	14
2014	11
2015	7
2016	18
2017	16
2018	13
2019	16
2020	44
2021	53
2022	31
2023	8
2024	0

1

Inflammation-Based Index and ⁶⁸Ga-DOTATOC PET-Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with ⁹⁰Y-DOTATOC.

Pauwels E, Van Binnebeek S, Vandecaveye V, Baete K, Vanbilloen H, Koole M, Mottaghy FM, Haustermans K, Clement PM, Nackaerts K, Van Cutsem E, Verslype C, Deroose CM. Pauwels E, et al. J Nucl Med. 2020 Jul;61(7):1014-1020. doi: 10.2967/jnumed.119.236935. Epub 2019 Dec 5. J Nucl Med. 2020. PMID: 31806775 Free article.

2

Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate?

Ezziddin S, Lohmar J, Yong-Hing CJ, Sabet A, Ahmadzadehfar H, Kukuk G, Biersack HJ, Guhlke S, Reichmann K. Ezziddin S, et al. Clin Nucl Med. 2012 Jun;37(6):e141-7. doi: 10.1097/RLU.0b013e31823926e5. Clin Nucl Med. 2012. PMID: 22614212

3

Clinical Assessment of 177Lu-DOTATATE Quantification by Comparison of SUV-Based Parameters Measured on Both Post-PRRT SPECT/CT and 68Ga-DOTATOC PET/CT in Patients With Neuroendocrine Tumors: A Feasibility Study.

Thuillier P, Maajem M, Schick U, Blanc-Beguin F, Hennebicq S, Metges JP, Salaun PY, Kerlan V, Bourhis D, Abgral R. Thuillier P, et al. Clin Nucl Med. 2021 Feb 1;46(2):111-118. doi: 10.1097/RLU.0000000000003412. Clin Nucl Med. 2021. PMID: 33234927

4

Prognostic Value of ¹⁸F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy.

Zhang J, Liu Q, Singh A, Schuchardt C, Kulkarni HR, Baum RP. Zhang J, et al. J Nucl Med. 2020 Nov;61(11):1560-1569. doi: 10.2967/jnumed.119.241414. Epub 2020 Mar 13. J Nucl Med. 2020. PMID: 32169914 Free article.

5

Peptide receptor radionuclide therapy of neuroendocrine tumors with (90)Y-DOTATOC: is treatment response predictable by pre-therapeutic uptake of (68)Ga-DOTATOC?

Öksüz MÖ, Winter L, Pfannenberg C, Reischl G, Müssig K, Bares R, Dittmann H. Öksüz MÖ, et al. Diagn Interv Imaging. 2014 Mar;95(3):289-300. doi: 10.1016/j.diii.2013.07.006. Epub 2013 Sep 12. Diagn Interv Imaging. 2014. PMID: 24034971 Free article.

6

[⁶⁸Ga]Ga-DOTATATE-avid tumor volume, uptake and inflammation-based index correlate with survival in neuroendocrine tumor patients treated with [¹⁷⁷Lu]Lu-DOTATATE PRRT.

Pauwels E, Dekervel J, Verslype C, Clement PM, Dooms C, Baete K, Goffin K, Jentjens S, Van Laere K, Van Cutsem E, Deroose CM. Pauwels E, et al. Am J Nucl Med Mol Imaging. 2022 Oct 15;12(5):152-162. eCollection 2022. Am J Nucl Med Mol Imaging. 2022. PMID: 36419585 Free PMC article.

7

Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.

Velikyan I, Sundin A, Sörensen J, Lubberink M, Sandström M, Garske-Román U, Lundqvist H, Granberg D, Eriksson B. Velikyan I, et al. J Nucl Med. 2014 Feb;55(2):204-10. doi: 10.2967/jnumed.113.126177. Epub 2013 Dec 30. J Nucl Med. 2014. PMID: 24379222 Free article. Clinical Trial.

8

Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from ⁶⁸Ga-DOTATOC PET/CT in Well-Differentiated Neuroendocrine Tumors.

Thuillier P, Liberini V, Grimaldi S, Rampado O, Gallio E, Santi B, Arvat E, Piovesan A, Filippi R, Abgral R, Molinari F, Deandreis D. Thuillier P, et al. J Nucl Med. 2022 Jul;63(7):1014-1020. doi: 10.2967/jnumed.121.262652. Epub 2021 Nov 5. J Nucl Med. 2022. PMID: 34740949 Free article.

9

Comparison of renal uptake of 68Ga-DOTANOC PET/CT and estimated glomerular filtration rate before and after peptide receptor radionuclide therapy in patients with metastatic neuroendocrine tumours.

Kaewput C, Vinjamuri S. Kaewput C, et al. Nucl Med Commun. 2016 Dec;37(12):1325-1332. doi: 10.1097/MNM.0000000000000591. Nucl Med Commun. 2016. PMID: 27612032

10

68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.

Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C. Poeppel TD, et al. J Nucl Med. 2011 Dec;52(12):1864-70. doi: 10.2967/jnumed.111.091165. Epub 2011 Nov 9. J Nucl Med. 2011. PMID: 22072704 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

227 results

Results by year